-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lyra Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2019 to Q2 2024.
- Lyra Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $855K, a 4.68% decline year-over-year.
- Lyra Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $4.47M, a 50.9% increase year-over-year.
- Lyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.5M, a 332% increase from 2022.
- Lyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.04M, a 921% increase from 2021.
- Lyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $102K, a 24.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)